SiTime to Present at the Raymond James TMT and Consumer Conference on December 10
SANTA CLARA, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — SiTime Corporation (Nasdaq: SITM), the Precision Timing company, today announced that […]
NKGen Biotech Selected as Stalking Horse Bidder for NKMax
Upon closing, the transaction would secure global IP rights for NKGen. NKGen and its partners can begin to commercialize troculeucel […]
Inari Medical Announces Joint Venture in Greater China
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]
Interparfums, Inc. To Develop Off-White Brand in Fragrance and Beauty Category
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) — Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced that […]
Zscaler Reports First Quarter Fiscal 2025 Financial Results
First Quarter Highlights Revenue grows 26% year-over-year to $628.0 million Calculated billings grows 13% year-over-year to $516.7 million Deferred revenue […]
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
WARSAW, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively […]
vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference
HIGH POINT, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company with […]
Credo Reports Second Quarter of Fiscal Year 2025 Financial Results
SAN JOSE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Credo Technology Group Holding Ltd (Nasdaq: CRDO), an innovator in providing […]
Aimfinity Investment Corp. I Announces Extension of the Deadline for an Initial Business Combination to December 28, 2024
Wilmington, Delaware, Dec. 02, 2024 (GLOBE NEWSWIRE) — Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special […]
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with […]
